RCAG
HRTX icon

Rehmann Capital Advisory Group’s Heron Therapeutics HRTX Stock Holding History

Rehmann Capital Advisory Group’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-32
Closed -$1.24K – 2163
2018
Q2 		$1.24K Buy
+32
New +$1.24K ﹤0.01% 1917